News

A psychedelic nasal spray requiring a much shorter period of clinical supervision has shown promise against ...
Lupin Ltd has introduced Ipratropium Bromide nasal spray in the US, available in 0.03% and 0.06% strengths. These sprays, ...
Mumbai: Global pharma major Lupin Limited has launched Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in ...
MomMed, a trusted maternal and family wellness brand, today announced a strategic partnership with nasal care innovator ...
Lupin has announced the launch of Ipratropium Bromide Nasal Solution (nasal spray) in two strengths in the United States.
As respiratory illnesses like COVID-19, influenza, and Mycoplasma pneumonia continue to spread, the need for safe, ...
BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...
The FTC sued Xlear after it marketed its spray as a covid preventative. The Trump administration dropped the suit, but the ...
Dosing began at Weill Cornell Medical Center in a Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS.
Danish allergy immunotherapy specialist ALK Abello today announced the first market launch of EURneffy (epinephrine) 2mg (the ...
Before using the nasal spray, it is advisable to follow the manufacturer’s instructions. Usually, this may involve shaking the bottle before use and priming the nasal spray if it is new or if a ...
Xlear is asking a federal judge to declare that the FTC Act does not include any requirement for companies to substantiate ...